Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Elixir enters license agreement with Boston University for SIRT1 modulators

July 4, 2008

NIH awards phase II SBIR grant to Pressure BioSciences to develop PCT

July 1, 2008

DSM and Crucell achieve new record in production of IgG antibodies using PER.C6

June 17, 2008

Lipoxen receives grant from IAVI to research improved HIV vaccine delivery using ImuXen

June 17, 2008

BioWa licenses Potelligent technology to Novartis for antibody research

June 13, 2008

Symphogen collaborates with Genentech for antibody therapeutics

June 13, 2008

Epix identifies three lead candidates in third G-protein-coupled receptor discovery program

June 9, 2008

Arana successfully engineers second candidate antibody under collaboration with CSL

June 9, 2008

PsychoGenics and Roche collaborate in neuropsychiatric disorder drug discovery

May 28, 2008

Novel mechanism for benzodiazepine receptor ligand PK-11195 identified

May 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...